Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2003 Jun;74(6):743–748. doi: 10.1136/jnnp.74.6.743

Should asymptomatic patients with hereditary haemorrhagic telangiectasia (HHT) be screened for cerebral vascular malformations? Data from 22 061 years of HHT patient life

A Easey 1, G Wallace 1, J Hughes 1, J Jackson 1, W Taylor 1, C Shovlin 1
PMCID: PMC1738468  PMID: 12754343

Abstract

Background: The frequency of haemorrhage in individuals with hereditary haemorrhagic telangiectasia (HHT), 10% of whom will have cerebral arteriovenous (AV) malformations, could be high enough to justify screening. This would allow presymptomatic treatment to prevent early onset stroke in a condition that affects at least 1 in 8000 individuals. This is an important issue in view of the contrast between transatlantic management approaches, the worldwide dissemination of patient information, and the ethical implications of the diagnosis for the untreated patient.

Objectives: To define the annual incidence of haemorrhagic stroke in individuals with HHT.

Methods: Retrospective study on stroke incidence in individuals with HHT and their immediate families (n = 674; 22 061 HHT patient years), specifically analysing patients under 46 years of age (17 515 patient years). The results were compared with stroke risk in the general population.

Results: In the majority of cases, the haemorrhage was the first significant neurological event. Overcorrecting for any bias towards overestimation that would be introduced in excluding non-penetrant family members, cerebral haemorrhages were more than 20 times more common in male HHT subjects under the age of 45 years than in the general population (standardised ratio 22.99; 95% confidence interval, 13.14 to 37.33). Haemorrhages were also six times more common in female HHT subjects (6.18; 2.27 to 13.45). The incidence ratio of cerebral haemorrhage in male patients (1.84; 1.05 to 2.99) yielded a haemorrhage rate in individuals with cerebral AV malformations of 1.4–2.0% per annum, comparable to figures in the non-HHT cerebral AV malformation population.

Conclusions: These data contradict accepted wisdom in many countries that asymptomatic HHT patients are at a low (and acceptable) risk of haemorrhage. The data justify a more aggressive screening approach to identify small causative lesions amenable to treatment.

Full Text

The Full Text of this article is available as a PDF (107.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bamford J., Sandercock P., Dennis M., Warlow C., Jones L., McPherson K., Vessey M., Fowler G., Molyneux A., Hughes T. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1373–1380. doi: 10.1136/jnnp.51.11.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bideau A., Brunet G., Heyer E., Plauchu H., Robert J. M. An abnormal concentration of cases of Rendu-Osler disease in the Valserine valley of the French Jura: a genealogical and demographic study. Ann Hum Biol. 1992 May-Jun;19(3):233–247. doi: 10.1080/03014469200002112. [DOI] [PubMed] [Google Scholar]
  3. Bonita R., Beaglehole R., North J. D. Event, incidence and case fatality rates of cerebrovascular disease in Auckland, New Zealand. Am J Epidemiol. 1984 Aug;120(2):236–243. doi: 10.1093/oxfordjournals.aje.a113885. [DOI] [PubMed] [Google Scholar]
  4. Brown R. D., Jr, Wiebers D. O., Forbes G., O'Fallon W. M., Piepgras D. G., Marsh W. R., Maciunas R. J. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1988 Mar;68(3):352–357. doi: 10.3171/jns.1988.68.3.0352. [DOI] [PubMed] [Google Scholar]
  5. Crawford P. M., West C. R., Chadwick D. W., Shaw M. D. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry. 1986 Jan;49(1):1–10. doi: 10.1136/jnnp.49.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dakeishi Miwako, Shioya Takanobu, Wada Yasuhiko, Shindo Tsutomu, Otaka Kousei, Manabe Motomu, Nozaki Jun-Ichi, Inoue Sumiko, Koizumi Akio. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. 2002 Feb;19(2):140–148. doi: 10.1002/humu.10026. [DOI] [PubMed] [Google Scholar]
  7. Daly L. E. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol. 1998 Apr 15;147(8):783–790. doi: 10.1093/oxfordjournals.aje.a009523. [DOI] [PubMed] [Google Scholar]
  8. Fisher W. S., 3rd Decision analysis: a tool of the future: an application to unruptured arteriovenous malformations. Neurosurgery. 1989 Jan;24(1):129–135. doi: 10.1227/00006123-198901000-00025. [DOI] [PubMed] [Google Scholar]
  9. Fleetwood Ian G., Steinberg Gary K. Arteriovenous malformations. Lancet. 2002 Mar 9;359(9309):863–873. doi: 10.1016/S0140-6736(02)07946-1. [DOI] [PubMed] [Google Scholar]
  10. Fulbright R. K., Chaloupka J. C., Putman C. M., Sze G. K., Merriam M. M., Lee G. K., Fayad P. B., Awad I. A., White R. I., Jr MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol. 1998 Mar;19(3):477–484. [PMC free article] [PubMed] [Google Scholar]
  11. Graf C. J., Perret G. E., Torner J. C. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 1983 Mar;58(3):331–337. doi: 10.3171/jns.1983.58.3.0331. [DOI] [PubMed] [Google Scholar]
  12. Gupta P., Mordin C., Curtis J., Hughes J. M. B., Shovlin C. L., Jackson J. E. Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients. AJR Am J Roentgenol. 2002 Aug;179(2):347–355. doi: 10.2214/ajr.179.2.1790347. [DOI] [PubMed] [Google Scholar]
  13. Guttmacher A. E., Marchuk D. A., White R. I., Jr Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995 Oct 5;333(14):918–924. doi: 10.1056/NEJM199510053331407. [DOI] [PubMed] [Google Scholar]
  14. Haitjema T., Disch F., Overtoom T. T., Westermann C. J., Lammers J. W. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med. 1995 Nov;99(5):519–524. doi: 10.1016/s0002-9343(99)80229-0. [DOI] [PubMed] [Google Scholar]
  15. Henkes H., Nahser H. C., Berg-Dammer E., Weber W., Lange S., Kühne D. Endovascular therapy of brain AVMs prior to radiosurgery. Neurol Res. 1998 Sep;20(6):479–492. doi: 10.1080/01616412.1998.11740552. [DOI] [PubMed] [Google Scholar]
  16. Itoyama Y., Uemura S., Ushio Y., Kuratsu J., Nonaka N., Wada H., Sano Y., Fukumura A., Yoshida K., Yano T. Natural course of unoperated intracranial arteriovenous malformations: study of 50 cases. J Neurosurg. 1989 Dec;71(6):805–809. doi: 10.3171/jns.1989.71.6.0805. [DOI] [PubMed] [Google Scholar]
  17. Kjeldsen A. D., Oxhøj H., Andersen P. E., Elle B., Jacobsen J. P., Vase P. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest. 1999 Aug;116(2):432–439. doi: 10.1378/chest.116.2.432. [DOI] [PubMed] [Google Scholar]
  18. Maher C. O., Piepgras D. G., Brown R. D., Jr, Friedman J. A., Pollock B. E. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke. 2001 Apr;32(4):877–882. doi: 10.1161/01.str.32.4.877. [DOI] [PubMed] [Google Scholar]
  19. Maraire J. N., Awad I. A. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995 Oct;37(4):591–605. doi: 10.1227/00006123-199510000-00001. [DOI] [PubMed] [Google Scholar]
  20. Ondra S. L., Troupp H., George E. D., Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg. 1990 Sep;73(3):387–391. doi: 10.3171/jns.1990.73.3.0387. [DOI] [PubMed] [Google Scholar]
  21. Pikus H. J., Beach M. L., Harbaugh R. E. Microsurgical treatment of arteriovenous malformations: analysis and comparison with stereotactic radiosurgery. J Neurosurg. 1998 Apr;88(4):641–646. doi: 10.3171/jns.1998.88.4.0641. [DOI] [PubMed] [Google Scholar]
  22. Shovlin C. L., Guttmacher A. E., Buscarini E., Faughnan M. E., Hyland R. H., Westermann C. J., Kjeldsen A. D., Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000 Mar 6;91(1):66–67. doi: 10.1002/(sici)1096-8628(20000306)91:1<66::aid-ajmg12>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  23. Shovlin C. L., Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax. 1999 Aug;54(8):714–729. doi: 10.1136/thx.54.8.714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Willemse R. B., Mager J. J., Westermann C. J., Overtoom T. T., Mauser H., Wolbers J. G. Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg. 2000 May;92(5):779–784. doi: 10.3171/jns.2000.92.5.0779. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES